SUBPROJECT 3

$1,429,305U54FY2008GMNIH

Sgx Pharmaceuticals, Inc., San Diego CA

Investigators

Lawrence Shapirocontact

Linked publications & trials

Paper 29767960 Paper 26312481 Paper 25608448 Paper 25170437 Paper 25145794 Paper 25139911 Paper 24980702 Paper 24926996 Paper 24872444 Paper 24831290 Paper 24697546 Paper 24060347 Paper 24056934 Paper 23848398 Paper 23499021 Paper 23332703 Paper 23295479 Paper 23214420 Paper 23192024 Paper 23035785 Paper 23006625 Paper 22544723 Paper 22475079 Paper 22323229 Paper 22090314 Paper 22090313 Paper 22072612 Paper 21998098 Paper 21914803 Paper 21710971 Paper 21482623 Paper 21387413 Paper 21365675 Paper 21275375 Paper 21247091 Paper 21185305 Paper 21130021 Paper 21097780 Paper 21070950 Paper 20943661 Paper 20737437 Paper 20685133 Paper 20624592 Paper 20604542 Paper 20415463 Paper 20310066 Paper 20156452 Paper 20088583 Paper 20057058 Paper 20052679 Paper 20004163 Paper 19883118 Paper 19857646 Paper 19805034 Paper 19788317 Paper 19787770 Paper 19760129 Paper 19660503 Paper 19472362 Paper 19426233 Paper 19381286 Paper 19358546 Paper 19357100 Paper 19352362 Paper 19281183 Paper 19251641 Paper 19220063 Paper 19219566 Paper 19079550 Paper 18948282 Paper 18832340 Paper 18754693 Paper 18722006 Paper 18542890 Paper 18505562 Paper 18442260 Paper 18334216 Paper 18275820 Paper 18247349 Paper 18245086 Paper 18235434 Paper 18210369 Paper 18184575 Paper 18175317 Paper 18058037 Paper 17910070 Paper 17908300 Paper 17640072 Paper 16756997 Paper 16511207 Paper 16459078 Paper 16381869 Paper 16216579

Abstract

ABSTRACT NOT PROVIDED

View original record on NIH RePORTER →